Moises Lustgarten, MD
Interventional Pain Medicine · Miami, FLNPI 1518947324
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,121 of the $3,132 with a category attached, or 67.7%. Abbott accounts for 69.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $1,630 and has fallen 90.8% since, to $150 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in FL, where the typical reported total is $4,625.
Across 50 payments — averaging $62.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Saluda Medical Americas, Inc.$450
- Boston Scientific$178
- Painteq LLC$163
- Almatica Pharma LLC$93
- Masimo Corporation$34
- plus $47 from 2 others
What the payments were for
- Travel & lodging$1,01132%
- Food & beverage$2,12168%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 34 | $2,167 |
| Saluda Medical Americas, Inc. | 5 | $450 |
| Boston Scientific | 3 | $178 |
| Painteq LLC | 1 | $163 |
| Almatica Pharma LLC | 4 | $93 |
| Masimo Corporation | 1 | $34 |
| Vertex | 1 | $25 |
| Stimwave Technologies Incorporated | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim IPG$719
- Proclaim DRG IPG$534
- PROCLAIM$406
- Evoke$315
- PAINTEQ$163
- Evoke SCS$110
How this compares
$3,132 in reported general payments places this provider in the 40th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 27 | $31,921 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 256 | $9,849 |
| Morphine Sulfate ErMorphine Sulfate | 113 | $5,618 |
| Fentanyl | 39 | $3,807 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 107 | $2,943 |
| Oxycodone Hcl | 129 | $2,204 |
| Hydromorphone Hcl | 63 | $2,031 |
| Pregabalin | 70 | $1,665 |
| Celecoxib | 80 | $1,595 |
| Tramadol Hcl | 216 | $1,579 |
| Morphine Sulfate | 27 | $1,110 |
| Diclofenac Sodium | 52 | $885 |
| Gabapentin | 43 | $565 |
| Methadone Hcl | 13 | $237 |
| Methylprednisolone | 23 | $219 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Miami
- Dennis PatinMiami$91K
- Javier VilasusoMiami$51K
- Joaquin Maury OchoaMiami$14K
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.